India hospital covid-19 patient India

Monoclonal antibody therapy can reduce hospitalization in covid, shows study

Reading now: 664
www.livemint.com

Open Forum Infectious Diseases journal. Investigational monoclonal antibody therapies, administered intravenously, are specifically designed to block infection by SARS-CoV-2, the virus that causes covid-19.

Similar to antibodies which are proteins that the body naturally produces to defend itself against disease, monoclonal antibodies are artificially created in the lab, tailor-made to fight the disease they treat.

The therapy is being frequently used in India and several parts of the world for the treatment of covid-19. The FDA has granted emergency use authorization (EUA) of MABs in outpatients with mild-to-moderate covid-19 at increased risk of developing severe disease.

Read more on livemint.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA